ARGOS THERAPEUTICS INC: 10-Q filed 2014-08-14
What ARGOS THERAPEUTICS INC reported in its quarterly report filed 2014-08-14 (fiscal Q2 2014): 30 published measures, 85 facts as tagged in accession 0001171843-14-003971.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2014-08-14
- Fiscal period
- fiscal Q2 2014
- Accession
- 0001171843-14-003971 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ARGOS THERAPEUTICS INC filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 74,717,872 | USD | |
| At 2013-12-31 | 51,131,295 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 60,558,168 | USD | |
| At 2013-12-31 | -75,776,593 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 44,307,394 | USD | |
| At 2013-12-31 | 33,297,970 | USD | |
| At 2013-06-30 | 3,352,992 | USD | |
| At 2012-12-31 | 8,214,865 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | -11,983,531 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -21,984,511 | USD | 181 |
| 2013-04-01 to 2013-06-30 | -5,778,841 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -10,228,043 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 486,372 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 363,746 | USD | 181 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 473,163 | USD | 91 |
| 2013-01-01 to 2014-06-30 | 1,271,951 | USD | 546 |
| 2013-04-01 to 2013-06-30 | 1,263,008 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 2,724,695 | USD | 181 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 0 | USD | 181 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 1,822,043 | USD | |
| At 2013-12-31 | 1,602,103 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 1,211,509 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 385,546 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | -11,961,793 | USD | 91 |
| 2013-01-01 to 2014-06-30 | -21,568,676 | USD | 546 |
| 2013-04-01 to 2013-06-30 | -5,779,037 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -10,585,168 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 72,884,809 | USD | |
| At 2013-12-31 | 49,528,642 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 171,604 | USD | 91 |
| 2013-01-01 to 2014-06-30 | 346,436 | USD | 546 |
| 2013-04-01 to 2013-06-30 | 171 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 361 | USD | 181 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 3,759,625 | USD | |
| At 2013-12-31 | 3,163,313 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 2,243,058 | USD | |
| At 2013-12-31 | 1,317,072 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 12,434,956 | USD | 91 |
| 2013-01-01 to 2014-06-30 | 22,840,627 | USD | 546 |
| 2013-04-01 to 2013-06-30 | 7,042,045 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 13,309,863 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 10,569,134 | USD | 91 |
| 2013-01-01 to 2014-06-30 | 19,041,329 | USD | 546 |
| 2013-04-01 to 2013-06-30 | 6,102,320 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 11,291,781 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 19,655,579 | shares | |
| At 2013-12-31 | 235,707 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 233,489,591 | USD | |
| At 2013-12-31 | 75,189,950 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | -102,320 | USD | |
| At 2013-12-31 | -102,531 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 9,802,194 | USD | |
| At 2013-12-31 | 9,766,135 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 7,980,151 | USD | |
| At 2013-12-31 | 8,164,032 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 11,020 | USD | |
| At 2013-12-31 | 550 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 1,470,397 | USD | |
| At 2013-12-31 | 1,800,794 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 818,581 | USD | |
| At 2013-12-31 | 629,935 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | -11,983,531 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -21,984,511 | USD | 181 |
| 2013-01-01 to 2014-06-30 | -21,984,511 | USD | 546 |
| 2013-04-01 to 2013-06-30 | -5,778,841 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -10,228,043 | USD | 181 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | -11,983,531 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -22,847,737 | USD | 181 |
| 2013-01-01 to 2014-06-30 | -22,847,737 | USD | 546 |
| 2013-04-01 to 2013-06-30 | -5,789,287 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -10,303,429 | USD | 181 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 1,865,822 | USD | 91 |
| 2013-01-01 to 2014-06-30 | 3,799,298 | USD | 546 |
| 2013-04-01 to 2013-06-30 | 939,725 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 2,018,082 | USD | 181 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 135,997 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 266,149 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 166,269 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 329,598 | USD | 181 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | -21,738 | USD | 91 |
| 2013-01-01 to 2014-06-30 | -415,835 | USD | 546 |
| 2013-04-01 to 2013-06-30 | 196 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 357,125 | USD | 181 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 925,986 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 938,313 | USD | 181 |
Inspect the source
- Entity
- ARGOS THERAPEUTICS INC / CIK 0001105533
- Captured
- SEC response SHA-256
07ee84a7b42518f1df0d6d45cc8782b7755c6cd7cd844b2cc13a94f0396ce00f
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001105533.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))